Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
08 May 2024
On 8 April 2024, the Dutch Minister of Medical Care sent a letter to Dutch Parliament (in Dutch: “Tweede Kamer”) regarding interactions between life sciences companies and...
Insights and Analysis
07 May 2024
The Q1/24 Life Science and Health Care Law Update covers key trends across EU life sciences regulatory, corporate, compliance, competition, and privacy.Key new developments: Pharma: EC ...
News
07 May 2024
On April 26, 2024, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) and the Centers for Medicare & Medicaid Services (CMS) finalized updates to...
News
06 May 2024
The U.S. Food and Drug Administration (FDA) has finalized its historic — and notoriously controversial — rule to explicitly assert the agency’s authority to regulate...
News
06 May 2024
On May 3, 2024, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for initial price applicability year (IPAY) 2027 of the Drug Price Negotiation Program...
News
02 May 2024
On April 22, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the Medicaid and Children's Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality...
News
25 April 2024
The HIPAA Privacy Rule has been modified by the US Department of Health and Human Services (“HHS”) to increase privacy protections for reproductive health care information....
News
19 April 2024
On April 19, 2024, the Health Resources and Services Administration (HRSA) published a final rule (Final Rule) in the Federal Register adopting several changes to the current administrative ...
News
18 April 2024
While economic factors, including the high cost of capital, continue to keep our clients up at night, we also see signs of optimism in 2024. Against this fiscal backdrop, significant recent ...
